, we set out to determinewhether any consistent differences couldbe found in the NMR spectralproperties ofVLDL, LDL, and HDL obtainedfrom cancer patients. The results of these measurements have providedimportantinsightintothe underlying mechanism of the "Fossel test" for cancer and have also served as the impetus for development of a new assay for plasma lipoproteins (12).
signal. Analysis of the concentrations of lipoprotein lipid and of 500 MHz NMR spectra of the lipoprotein constituents in >100 plasma samples failed to provide support for either hypothesis. Although linewidths were found to be significantly narrower for thecancer group, the difference isentirely attributable todifferences intheconcentrations of the lipoproteins. report of Fossel et al. (1) , which claimedthat proton nuclear magnetic resonance (NMR) spectra of human plasma could accurately differentiate healthy individuals from those with many different types of malignancies. 6 The variable used to distinguish the two groups was the average linewidth of the two prominent resonances in the spectrum arising from the methylene and methyl protons of the plasma lipids. The narrower linewidths observed for cancer patients were originally postulated to originate from differences in spin-spin (T2) relaxation time, arising from enhanced lipid mobility in lipoprotein structures having less "supramolecular ordering." With our current knowledge, such malignancyassociated differences in lipoprotein structure, if they exist, are unlikelytohave a dominant effect on plasma lipid linewidths, which are now recognized to be influenced less by T2 relaxation than by chemical shift heterogeneity (2) (3) (4) (5) (6) . The methyl and methylene resonances of blood plasma are now known to be composite peaks consisting of partly overlapped narrower signals from the protons of several types of lipid molecules in the majorclasses of lipoproteins: very-low-(VLDL), low-(LDL), and high-density lipoprotein (HDL). This improved understanding of the nature of the plasma spectrum has led several groups (4) (5) (6) (7) (8) (9) (10) to suggest that observed differences in lipid linewidth between individuals with and without cancer result primarily from known alterations in plasma lipoprotein metabolism associated with malignancy (11) . Specifically, cancer patientson average exhibitincreasedVLDL and decreased HDL concentrations, the combination of which would produce narrower linewidths.
For proton NMR spectroscopy of plasma to have potential as a marker of malignant disease, it must provide demonstrably better diagnostic discrimination than existing methods. Because the NMR linewidth correlates to some extent with variations in plasma lipid concentrations (5) (6) (7) (8) (9) , proponents must document whether NMR provides any greater discrimination between cancer and healthy populationsthan may be achievedby measuring lipoproteins by standard chemicalmeans. Until now, this questionhas not been directly addressed.
The presentstudy was designedto examine several factors that might influence the overalllineshapes of the plasma lipid signals and hence their linewidths.
Because each plasma lipid resonance is composed of the superimposed resonances from the different lipoprotein classes (2, 5, 6) , we set out to determinewhether any consistent differences couldbe found in the NMR spectralproperties ofVLDL, LDL, and HDL obtainedfrom cancer patients. The results of these measurements have providedimportantinsightintothe underlying mechanism of the "Fossel test" for cancer and have also served as the impetus for development of a new assay for plasma lipoproteins (12) .
years. The cancer group consisted of 81 men and 30 women, ages 23 to84 years,who had newly diagnosed, biopsy-proven malignanciesbut had not yet received any therapy. The patients were classified by primary site of disease as follows: breast (n = 15), genitourinary tract(n = 3), head and neck (n = 28), lung (n = 22), gastrointestinal (n = 13), prostate (n = 13), and other (n = 17). (14) . LDL cholesterol was estimated from the total cholesterol, HDL cholesterol, and triglyceride values by the method of Friedewald et al. (15) . Total proteinwas measured by the biuretmethod (16) and albumin by a modification of the bromcresolgreen bindingmethod of Doumas and Biggs (17) . All standards for protein, albumin, and lipids were from Sigma, aswere AccutrolTM normal and abnormal serum controls used to maintain quality control for sequential measurements. All reported lipid and protein values are the average of duplicate determinations.
Lipoprotein Fractionation
Lipoprotein constituents from about half of the plasma samples were isolated by sequential flotation ultracentrifugation as described by Schumaker and Puppione (18) . For the purposes of this study, plasma was consideredto be composed of four components having the followinghydrated densityranges:VLDL In the initial stages of the study, we subjected the plasma to only one centrifugation step (180 000 x g, 18 h) so we could isolate in pure form the VLDL and protein (obtained from the top and bottom fractions, respectively, of plasma adjusted to densities of1.006and 1.21kgfL). Later, a secondcentrifugation step(180000 x g,22 h)was added totheprotocol toobtainpure LDL and E[DL also (18 
ms).
Spectra were run with the sample spinning after shimming the magnetic field on the lock signal. This yielded reproducibly good field homogeneity,as verified by the linewidth of the CaEDTA resonance in each spectrum (<3.5 Hz). Spectra were acquired with a 16-bit digitizer by using a standard one-pulse sequence preceeded by a 1-s selective presaturation pulse at the water frequency. A spatially selective composite 90#{176} observation pulse (9O-9O-9(L-9(L) was used to minimize water suppression artifacts (19) . Other acquisition characteristics were as follows: spectral width, 5600 Hz; data size, 8K; number of transients, 80. The timedomain data were zero-filled to 32K and multiplied by a 1-Hz exponential linebroadening function before Fourier transformation. Spectra were scaled identically to permit quantitative comparisons of amplitudes of the lipid signals. After phasing and referencing chemical shifts (seebelow),we applieda linear baseline correction to flatten the baseline between 1.8 and -0.2 ppm. This operation has no effect on measured linewidths or chemical shifts, but gives more reproducible peak heights and areas for the resonances in this region by eliminating the effects of any variability in quality of water suppression. Linewidthsof the methyl and methylene lipid signals were measured as described by Fossel et al. (1) , and 1 Hz was subtracted to compensate for the effect of the linebroadening function applied to the free induction decay. Also measured for each sample were the peak heights of the methyl and methylene signals (normalizedto the height of the peak from the TSP external standard) and the integrated areas of the methyl (0.95-0.70 ppm) and methylene (1.28-1.12 ppm) resonances (normalized to the area of the TSP peak). Not all of the downfield portion of the methylene peak was included in the integrated region because we wanted to avoid including any contribution from the variable lactate signal at 1.33 ppm.
Chemical shifts of all plasma resonances were referenced to the sharp CaEDTA signal at 2.519 ppm. However, we could not reference the resonances of the isolated lipoprotein constituents in the same manner becausethe chemicalshifts of the CaEDTA signal and those of the lipoprotein lipids were differentially affected by the increased salt concentrations that remained from the ultracentrifugal separations. We therefore obtainedspectra of representative plasma and lipoprotein samples adjusted to a series of different NaBr concentrations.
From these we established the linear relationships that exist between salt concentration (0-1.5 molIL) and the frequencies of the signals from water, CaEDTA, and the lipoprotein lipids. Subsequently, we used this information to let the observed water frequency of each sample serve as a chemical shift calibration reference so that we could convert the measured shifts of the lipid resonances to those expected in whole plasma.
Statistical Methods
The NMR measurements from subjects in the cancer and control groups were compared by either a Student's t-test or a Wilcoxon test (20) , the latter being a nonparametric test appropriate for small samples. We also examined NMR signal amplitudes per unit of lipoprothin lipid concentration by multiple-regression analyses, with integrated signal area as the dependent vanable. Independent variables in these analyses included lipid concentration, an indicator variable representing cancer status, and the interaction between lipid concentration and cancer status. The magnitude of the regression coefficients for the intercept and slopes (indicating whether the estimated regression lines for the two groups have the same intercept and are parallel, respectively) was examined (21) . Because of age and sex differences between the cancer patients and controls, these characteristics were included in the regression analyses as covariates.
Receiver-operator characteristic (ROC) curves were used to assess the sensitivity and specificity of various NMR parameters for the diagnosis of cancer as compared with standard lipid measures (22) . Because the sensitivity and specificity of a diagnostic test vary inversely with the cutpoint chosen, ROC curves are useful in sununarizing the accuracy of a diagnostic test over a wide range of cutoff values.
Results and DiscussIon

NMR Properties of Plasma Lipids
The two most prominent signals in the aliphatic region of 'H NMR spectra of human plasma appear at about 1.2 and 0.8 ppm and arise respectively from the methylene (CH2) and methyl (CH3) protons of plasma lipids. These signals are extremely heterogeneous, con- (2, 5, 6) . These differences are the root cause of the linewidth variations that have been claimed by Fossel et al. (1) to correlate with malignancy. The composite methyl and methylene signals of whole plasma arise from a simple linear combination of the resonances of its constituent lipoproteins, the amplitudes of which vary from person to person according to lipoprotein status. As a consequence, the lipid resonance envelopes of plasma samples exhibit complex and widely variablelineshapes. As Figure 1 
from VLDL, LDL, and HDL are superimposed. Because its amplitude is much greater in the methyl region than in the methylene region, it significantly contributes to the plasma methyl lineshape, particularly on the downfield side of the signal.
Plasma Lipoproteins from Cancer and Control Groups
Several investigators (4) (5) (6) (7) (8) (9) have suggested that the narrower lipid linewidths observed for cancer patients result from the fact that this population exhibits, on the average, increased concentrations of VLDL and decreased HDL (11) . The line-narrowing effect of an increased VLDL/HDL ratio is easily appreciated by comparing the top and bottom spectra of Figure 1 . Although malignancy-induced alterations in lipoprotein concentrations almost certainly contribute to the phenomena observed by Fossel et al. (1) , it has yet to be determined whether other line-narrowing mechanisms may also be operative. If so, the diagnostic potential of the Fossel linewidthfinding might be expected to be greater than alternative indicators based strictly on lipoprotein concentrations.
In the present study, we tested two alternative mechanisms by which NMR spectra (linewidth) of plasma samples could plausibly be affected by cancer: (a) malignancy-associated changes in the spectral properties (chemical shift, lineshape, CH2/CH3 ratio) of one or more of the plasma lipoproteins and (b) malignancyassociated differences for one or more of the lipoproteins in the fraction of lipid protons that are in a fluid, NMR-observable state. In the first case, plasma linewidths from a cancer group would be narrower if, for example, the linewidths of the VLDL or HDL components were narrower or their chemical shifts were closer together (see Figure 1) Table 1 . These data clearly establish the lack of significant differences in these variables between the cancer and control groups that could contribute to narrower composite plasma linewidths in the cancer group. To the contrary, we found (25, 26) . This unexpected finding prompted us to investigate the feasibility ofusingNMR lineshape analysis to quantify lipoprotein concentrations in plasma (12) .
To addressthequestionofwhether any of the lipoprothins from cancer patients give consistently greater or smaller NMR signal amplitudes per unit concentration than thosefrom a healthycontrol group, we generated the regression lines shown in Figure 2 . Plotted against the integrated areas of the lipid resonancesof VLDL, LDL, and HDL are the measured concentrations of the plasma lipids (triglyceride, LDL-cholesterol, and HDLcholesterol, respectively), which are routinely used as estimates of the concentrations of these lipoproteins.
Although the linear-regression lines through the data pointsforthe cancerand control groupswere notidenticalfor any of the lipoprotein classes, none of the differences in slope and intercept were statistically significant when adjusted for the age and sex differences of the populations. The same result was obtained when samples from patients with a particular stage of disease or type of malignancy were analyzed as separate groups. Thus, we found no supporting evidence for the hypothesis that narrower plasma linewidths of cancer patients might be due in part to systematic differences in the NMR detectability of their lipoprotein lipids.
For the overall population (cancer plus control), one can discern several relationships from the data in Fig-0 374 CLINICAL CHEMISTRY,Vol. 37, No. 3, 1991 ure 2. First, VLDL signal amplitude correlates very well with plasma triglyceride (r = 0.91). This is not unexpected, because most plasma triglyceride is found in VLDL, and VLDL is composed mainly of triglyceride.
Es
The correlation between LDL and HDL signal amplitudes and the corresponding concentrations of cholesterol in these particles is less strong (r = 0.64 and 0.66, respectively). Contributing factors are the experimental errors associated with the lipoprotein fractionation and the assays of total and HDL-cholesterol, and the assumptions upon which the estimation of LDL-cholesterol are based (15) . However, a more fundamental reason for the scatter in the data is that two different things are being compared, namely, the concentration of cholesterol in the particles and the concentration of "mobile" lipid protons within the particles, only part of which originates from cholesterol. Whether lipoprotein NMR signal amplitudes provide a better representation of actual lipoprotein particle concentrations than do cholesterol measurements is a question that requires further investigation.
Comparative Diagnostic Potential of Plasma Linewidth
A summary of the NMR and blood chemistry data obtained from the cancer and control groups is presented in Table 2 . In addition to the average values (± SD) observed for each variable for the male and female subpopulations and the overall group, we list the Wilcoxon z-statistic, a measure of the similarity of the median values between the cancer and control populations. As with the more frequently used Student's t-test, a higher value indicates that the observed differences are less likely due to chance; the Wilcoxon test, however, requires no assumptions about the underlying population distributions.
Interestingly, the variable found to give the best overall discrimination between the groups was serum albumin (z = 8.6, P <0.0001).
However, because decreased albumin concentrations are associated with many other disease states besides cancer, it is not clear whether this observation has any diagnostic significance.
In agreement with the results of Fossel et al. (1) and those of other investigators (4) (5) (6) (7) (8) (9) , we found that the average (±SD) plasma linewidth for the cancer group (30.3 ± 6.3 Hz) was significantly narrower than for the controls (36.2 ± 6.6 Hz) (P <0.0001). The difference observed in females was even greater (30.0 ± 6.2 vs 37.4 ± 6.4 Hz). Our contention that these linewidth differences arise soleiy from differences in lipoprotein concentration (correlating roughly with HDL/VLDL ratio) is supported by comparing the corresponding values for plasma triglyceride and HDL-cholesterol, which provide estimates of VLDL and HDL concentrations, respectively. As seen in Table 2 , the mean concentrations of triglyceride were significantly higher for the cancer group, the HDL-cholesterol lower. These results are in accord with those of previous studies showing increased concentrations of triglyceride associated with cancer in both humans and animals (11, 27, 28) and an inverse relationship between HDL and triglyceride (29 Table   2 ).
The degree towhich thisoverlapaffects the diagnostic utility ofthetwo variables isgraphically depicted by the ROC curves in Figure 4 (22) . Neither variable discriminates very accurately between the cancer and control populations, with 80% sensitivity beingachievedonlyat the expense of a 40% false-positive rate. Virtualsuperimposition of the two ROC curves in Figure 4 convincinglyindicates thatproton NMR does not provideany better clinical utility for cancer diagnosis than is provided by standard chemicalassaysforplasma lipoprothins. This conclusion isreinforced by the results of our detailed NMR analyses of the isolated lipoprotein constituents ofnumerous plasma samples,which failed to 
